Harvard Bioscience, Inc. Share Price

Harvard Bioscience, Inc. Share Price

NASDAQ: HBIO | Small Cap
$8.83
+$0.09 (1.03%) Last updated on 30 Oct, 2026 | 20:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Harvard Bioscience, Inc. Stock Performance

Open
$8.90
Prev. Close
$8.74
Circuit Range
N/A
Day Range
$8.83 - $8.90
Year Range
$0.40 - $8.95
Volume
702
Average Traded
$8.88

Harvard Bioscience, Inc. Share Price Today

As of 30 October 2026, Harvard Bioscience, Inc.'s share price is $8.83. The stock opened at $8.90, compared to its previous close of $8.74. During today's trading session, Harvard Bioscience, Inc.'s share price traded between $8.83 and $8.90, with an average price of $8.87. Over the past 52 weeks, the stock has recorded a high of $8.95 and a low of $0.40. In terms of performance, Harvard Bioscience, Inc.'s share price has risen by 35.43% over the last six months and is up 1604.63% on a year-on-year basis.

Harvard Bioscience, Inc. Share Price Chart

Line chart of the Harvard Bioscience, Inc. price trend over the selected period. The price rose overall, ranging from 8.81 to 8.94, ending at 8.83.
$8.83$8.90
L
Show Current Price
H

Harvard Bioscience, Inc. Stock Fundamentals & Key Indicators

Market Cap
$391.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.29
Revenue (TTM)
$86.55B
Return On Equity (TTM)
-140.36%
Profit Margin
-65.51%
Debt to Equity
4.94
Quarterly Earnings Growth YoY
-136.59%

Harvard Bioscience, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$20.59$23.74$20.76$22.73
Net Profit-$1.23-$2.85-$3.42-$2.91
Net Profit Margin-5.97%-12.01%-16.47%-12.80%
Income ChangeN/A-131.71%-20.00%14.91%

Harvard Bioscience, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$113.34$112.25$94.14$86.55
Net Profit-$9.52-$3.42-$12.41-$56.70
Net Profit Margin-8.40%-3.05%-13.18%-65.51%
Income ChangeN/A64.08%-262.87%-356.89%

About Harvard Bioscience, Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Harvard Bioscience, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$7.88
$8.83
+12.34%
Sep 2026
$8.03
$7.86
-0.51%
Aug 2026
$6.37
$7.90
+31.45%
Jul 2026
$6.20
$6.01
-2.51%
Jun 2026
$5.83
$6.17
+4.31%
May 2026
$6.21
$5.91
-9.36%
Apr 2026
$5.22
$6.52
+32.25%
Mar 2026
$0.61
$4.93
+700.32%
Feb 2026
$0.50
$0.62
+23.20%
Jan 2026
$0.65
$0.50
-24.59%
Dec 2025
$0.80
$0.66
-13.22%
Nov 2025
$0.53
$0.76
+47.49%

HBIO Share Price FAQs